Grand Pharmaceutical Group Limited
HKSE: 0512.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chao Zhou
- Employees
- 11,987
- Headquarters
- Central, Hong Kong SAR China
- IPO year
- 1995
- Market cap
- HK$21.5B
- Website
- https://www.grandpharm.com
Loading 0512…
Loading profile data…Frequently asked questions about 0512
What does Grand Pharmaceutical Group Limited (0512.HK) do?
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers pharmaceutical preparations, including cerebro-cardiovascular emergency m...
Where does 0512.HK trade?
Grand Pharmaceutical Group Limited (0512.HK) trades on the Hong Kong Stock Exchange.
What sector is 0512.HK in?
Grand Pharmaceutical Group Limited (0512.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Grand Pharmaceutical Group Limited?
Chao Zhou is the chief executive officer of Grand Pharmaceutical Group Limited (0512.HK).
Where is Grand Pharmaceutical Group Limited headquartered?
Grand Pharmaceutical Group Limited is headquartered in Hong Kong SAR China.
Does 0512.HK pay a dividend?
Yes — Grand Pharmaceutical Group Limited (0512.HK) paid a trailing twelve-month dividend of HKD 0.17 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 0512.HK go public?
Grand Pharmaceutical Group Limited (0512.HK) completed its initial public offering in 1995.